-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
R&D base
14
2025-01
The successful convening of this year's 2025 Annual Target Promotion and Implementation Meeting marks a solid step forward for Keyuan Pharmaceutical in planning and executing its strategic goals for 2025. By clarifying the direction, establishing clear guidelines, defining specific measures, and strengthening execution, the company has laid a robust foundation for smoothly advancing subsequent tasks—and ensuring that it achieves a strong start to both the first month and the first quarter!
2025-01-14
05
2025-01
The meeting began with a comprehensive review of the company’s safety production efforts for 2024. Over the past year, Keyuan Pharmaceutical has consistently adhered to the guiding principle of "Safety First, Prevention-Oriented, and Comprehensive Management." By strengthening safety management, refining safety protocols, and intensifying safety training, the company has effectively elevated its overall safety standards, successfully achieving its annual goals: "zero safety incidents, zero environmental pollution, and zero administrative penalties" for the entire year.
2025-01-05
31
2024-12
2024: Gleaming Footprints—The Annual Mark of Innovation and Breakthrough
2024 Shining Footprints: The Yearly Imprint of Innovation and Breakthroughs
2024-12-31
30
2024-12
At the vibrant peak of youth at twenty, it’s the perfect time to continue writing our inspiring chapter! In 2024, Keyuan Pharmaceutical celebrates its 20th anniversary. To mark this historic milestone, the company recently hosted a special symposium, inviting senior employees who have dedicated 20 years to the organization, as well as employee representatives from various generations who joined the company over the years. Together, they reflected on Keyuan’s remarkable two-decade journey and looked forward to shaping an even brighter future ahead.
2024-12-30
26
2024-12
The event kicked off with the rousing "Lino Anthem," as management presented the five core product teams—each representing isosorbide mononitrate, gliclazide, sacubitril valsartan sodium, mecobalamin, and lurasidone hydrochloride—with flags symbolizing both honor and responsibility. Each flag embodies the company's profound aspirations for future growth, and all employees are determined to work together seamlessly, jointly driving marketing efforts to new heights in the coming year.
2024-12-26
24
2024-12
For years, Keyuan Pharmaceutical has actively participated in various public welfare activities and donated a wide range of charitable materials, demonstrating its corporate social responsibility through concrete actions. This not only earned the company widespread recognition from society and enhanced its positive public image but also strengthened employee cohesion and sense of belonging, laying a solid social foundation for the company’s high-quality, sustainable growth.
2024-12-24
13
2024-12
Since the launch of the competition, all employees of Keyuan Pharmaceutical have enthusiastically responded, picking up their cameras or smartphones to capture the focus and passion at work, as well as the warmth and beauty in everyday life—from various perspectives.
2024-12-13
12
2024-12
Against the backdrop of China's Healthy China initiative, the pharmaceutical and healthcare industry is poised to embrace unprecedented growth opportunities—yet it also faces increasingly fierce market competition and mounting pressure to transform and upgrade. To tackle these challenges, strategic collaboration, resource sharing, and mutual complementation of strengths are key for companies to rise to the occasion and seize the emerging opportunities.
2024-12-12
11
2024-12
This training session was carefully organized by the Human Resources Center and the Safety Management Department, with special invitation extended to experienced, in-house Registered Safety Engineers who bring extensive hands-on expertise as instructors. The training covers a wide range of topics, including fundamental safety knowledge specific to chemical production, identification and prevention of common hazards during process operations, essential emergency response skills, and an in-depth analysis of the "Three Violations" management system (i.e., unauthorized command, improper work practices, and breaches of labor discipline). Tailored to address the unique challenges of chemical manufacturing, the program uses vivid case studies to thoroughly explain critical safety precautions at every stage—such as chemical storage, process operations, and waste disposal—thereby comprehensively enhancing employees' safety awareness and their ability to protect themselves effectively.
2024-12-11
04
2024-12
To further strengthen university-enterprise collaboration and promote the deep integration of industry, academia, and research, on December 3, Wei Zhanling, Secretary of the Party Committee of Nankai University’s School of Pharmacy, and her delegation visited Keyuan Pharmaceutical & Linuo Pharmaceutical, establishing a valuable opportunity for university-enterprise cooperation and jointly fostering scientific innovation and talent development in the pharmaceutical field. Jiang Hongsheng, Chairman and President of Keyuan Pharmaceutical, and his team accompanied the delegation during the visit and discussion.
2024-12-04
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline